Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Exatecan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 88,595Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cybrexa Therapeutics Announces Data Demonstrating Early Signals of Efficacy
    Cybrexa Therapeutics Announces Data Demonstrating Early Signals of Efficacy

    26 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/26/2320568/0/en/Cybrexa-Therapeutics-Announces-Data-Demonstrating-Early-Signals-of-Efficacy-and-Powerful-Potential-of-Antigen-Independent-Tumor-Targeting.html

    GLOBENEWSWIRE
    26 Oct 2021
    Share Share
    Cybrexa Therapeutics Enters Cooperative Research (CRADA)
    Cybrexa Therapeutics Enters Cooperative Research (CRADA)

    24 Feb 2021

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/cybrexa-therapeutics-enters-cooperative-research-crada-1616653061.pdf

    PRESS RELEASE
    24 Feb 2021
    Share Share
    Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12
    Cybrexa Therapeutics Completes Successful Pre-IND Meeting With FDA for CBX-12

    07 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/07/2058447/0/en/Cybrexa-Therapeutics-Completes-Successful-Pre-IND-Meeting-With-FDA-for-CBX-12-alphalex-exatecan-a-Novel-Treatment-for-Solid-Tumors.html

    GLOBENEWSWIRE
    07 Jul 2020
    Share Share